Evidence map›Paper›PMID 38773321›Full record

ArticleEMBO reports2024

ER-to-lysosome-associated degradation acts as failsafe mechanism upon ERAD dysfunction.

Elisa Fasana, Ilaria Fregno, Carmela Galli, Tatiana Soldà, Maurizio Molinari

Abstract read
In one paragraph

Article in EMBO reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Review
  6. SEL1L-HRD1 ERAD-autophagy interplay maintains mitochondrial homeostasis in brown adipocytes.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  7. FAM134B controls collagen I dynamics in hepatic stellate cell-driven fibrosis.American journal of physiology. Gastrointestinal and liver physiology · 2026
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. N-palmitoyl glycine mediates depression-associated atrial fibrillation via Man1a2-dependent autophagy and NRAP dysregulation.Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology · 2025
    Article
  17. Glycosylation Regulation by TMEM230 in Aging and Autoimmunity.International journal of molecular sciences · 2025
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Elisa Fasana *Faculty of Biomedical Sciences, Institute for Research in Biomedicine, Università della Svizzera italiana (USI), 6500, Bellinzona, Switzerland.
Ilaria Fregno *Faculty of Biomedical Sciences, Institute for Research in Biomedicine, Università della Svizzera italiana (USI), 6500, Bellinzona, Switzerland.ORCID 0000-0003-0546-8764
Carmela Galli *Faculty of Biomedical Sciences, Institute for Research in Biomedicine, Università della Svizzera italiana (USI), 6500, Bellinzona, Switzerland.
Tatiana SoldàFaculty of Biomedical Sciences, Institute for Research in Biomedicine, Università della Svizzera italiana (USI), 6500, Bellinzona, Switzerland.
Maurizio MolinariFaculty of Biomedical Sciences, Institute for Research in Biomedicine, Università della Svizzera italiana (USI), 6500, Bellinzona, Switzerland. maurizio.molinari@irb.usi.ch.ORCID 0000-0002-7636-5829

Funding

EC | H2020 | ERA-LEARN | Eurostars (Eureka) E!2228Innosuisse - Schweizerische Agentur für Innovationsförderung (Innosuisse) 35449.1 IP-LSSchweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (SNF) 310030_214903Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (SNF) 320030_227541
6 · The paper itself

Abstract

The endoplasmic reticulum (ER) produces proteins destined to organelles of the endocytic and secretory pathways, the plasma membrane, and the extracellular space. While native proteins are transported to their intra- or extracellular site of activity, folding-defective polypeptides are retro-translocated across the ER membrane into the cytoplasm, poly-ubiquitylated and degraded by 26 S proteasomes in a process called ER-associated degradation (ERAD). Large misfolded polypeptides, such as polymers of alpha1 antitrypsin Z (ATZ) or mutant procollagens, fail to be dislocated across the ER membrane and instead enter ER-to-lysosome-associated degradation (ERLAD) pathways. Here, we show that pharmacological or genetic inhibition of ERAD components, such as the α1,2-mannosidase EDEM1 or the OS9 ERAD lectins triggers the delivery of the canonical ERAD clients Null Hong Kong (NHK) and BACE457Δ to degradative endolysosomes under control of the ER-phagy receptor FAM134B and the LC3 lipidation machinery. Our results reveal that ERAD dysfunction is compensated by the activation of FAM134B-driven ERLAD pathways that ensure efficient lysosomal clearance of orphan ERAD clients.

Indexed as

Endoplasmic ReticulumEndoplasmic Reticulum-Associated DegradationLysosomesMembrane Proteinsalpha 1-AntitrypsinAmyloid Precursor Protein SecretasesAnimalsAspartic Acid EndopeptidasesHeLa CellsHumansIntracellular Signaling Peptides and ProteinsLectinsMiceProteasome Endopeptidase ComplexProtein FoldingProtein Transportalpha 1-AntitrypsinAmyloid Precursor Protein SecretasesAspartic Acid EndopeptidasesEDEM1 protein, humanIntracellular Signaling Peptides and ProteinsLectinsMembrane ProteinsProteasome Endopeptidase ComplexRETREG1 protein, humanEndoplasmic Reticulum (ER)ER-associated Degradation (ERAD)ER-phagyER-to-Lysosome-associated Degradation (ERLAD)Protein Quality Control

Identifiers

PMID38773321
PMCPMC11169228

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.